About
Andrew Technologies is a medical technology company committed to improving patients' lives through body aesthetics. Our HydraSolve™ lipoplasty system is a patented, FDA-cleared medical device that will be launched in 2012. HydraSolve™ utilizes low-energy Tissue Liquefaction Technology™, to change the nature of aesthetic body contouring. Combining natural saline solution with low levels of pressure and temperature, HydraSolve™ is able to remove only targeted fat tissue, while preserving other vital tissues. Because fat tissue is liquefied, the forceful shearing of fat is no longer required and this allows the surgeon to move the cannula in a slow, controlled, and methodical manner.
Technologies
Keywords
Company Information
-
Employees 3
-
Founded 2007
-
Total Funding $7800000
Location
152 West 57th Street, New York, New York, United States, 10019
